openPR Logo
Press release

Pharma Blister Packaging Market global status and business outlook 2019 to 2027

12-28-2020 07:49 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent market insights

Pharma Blister Packaging Market

Pharma Blister Packaging Market

Pharmaceuticals is the largest end-use industry in the blister packaging market. Tablets and capsules are widely sold in pharma blister packaging. The advantages are assurance of product safety and product packaging. Despite its advantages, pharma blister packaging is non-biodegradable and non-recyclable. This has led to environmental concerns regarding its large scale use.

Europe was accounted for significant market share in the global pharma blister packaging market in 2017 and expected to increase during forecast period. This owing to new product launches by key players in the European market. For instance, in 2016, Klockner Pentaplast launched Pentapharm LiquiGuard, a new range of pharmaceutical blister films. The new film offers low leachability, high heat stability, odor & flavor retention, and one stage forming & packaging of hot-fill products. The product can be used in wide range of applications such as nutraceuticals, chewables, pharmaceuticals, unit dose liquids, veterinary, and formulations sensitive to flavor or odor loss packaging.

Request For Sample Copy of this Report : https://www.coherentmarketinsights.com/insight/request-sample/3299

Increasing demand for pharma blister packaging across the globe is driving pharma blister packaging market growth. This is owing to its advantages over alternatives such as cost-effectiveness, enhanced durability, tamperproof, it improves shelf life, and lower risk of contamination. Pharma blister packaging is a plastic packaging and its function is to protect the packaged material from air, moisture, and contamination from external sources.

Market Taxonomy:-

On the basis of material type, the global pharma blister packaging market is segmented into:
Polyethylene Terephthalate (PET)
Polyethylene (PE)
Polyvinyl Chloride (PVC)
Aluminum
Paper & Paper Board
Others (Cyclic Olefin Polymers, etc.)

On the basis of technology, the global pharma blister packaging market is segmented into:
Cold Forming
Thermoforming

FLAT 25% DISCOUNT on all CMI Reports, Promo Code: CHRISTMAS2020

Request Discount of This Report:
https://www.coherentmarketinsights.com/insight/request-discount/3299

Players operating in the global pharma blister packaging include Amcor Plc, Wonderpack group, Bilcare Limited, Sonoco Products Company, Honeywell International Inc., ACG Pharmapack Pvt. Ltd., West Rock Company, Constantia Flexibles GmbH, WINPAK LTD, Rohrer Corporation, Accupack, Nichrome Packaging Solutions, Nirmala Industries, etc.

Contact Us:
Name: Mr. Shah
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
Visit Our Blogs: https://blog.coherentmarketinsights.com

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharma Blister Packaging Market global status and business outlook 2019 to 2027 here

News-ID: 2217374 • Views:

More Releases from Coherent market insights

Coated Tablets Market to Witness Massive Growth by 2033 | Pfizer, Novartis, Roche, Johnson and Johnson
Coated Tablets Market to Witness Massive Growth by 2033 | Pfizer, Novartis, Roch …
The global coated tablets market is estimated to be valued at USD 1.04 Bn in 2026 and is expected to reach USD 1.96 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033. The latest report by Coherent Market Insights indicates strong growth potential for the Coated Tablets Market from 2026 to 2033, supported by rising industry demand, expanding applications, and ongoing technological advancements. The
Cattle Vaccine Market Set to Witness Significant Growth by 2026-2033 | Zoetis, Boehringer Ingelheim Animal Health, Merck Animal Health MSD Animal Health, Elanco Animal Health
Cattle Vaccine Market Set to Witness Significant Growth by 2026-2033 | Zoetis, B …
The global cattle vaccine market is estimated to be valued at USD 4.13 Bn in 2026 and is expected to reach USD 6.17 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Cattle Vaccine Market. From 2026 to
Fish Oil Market to Witness Massive Growth by 2033| DSM Nutritional Products, Royal DSM, NutraScience Laboratories, Omega Protein Corporation
Fish Oil Market to Witness Massive Growth by 2033| DSM Nutritional Products, Roy …
The global fish oil market is estimated to be valued at USD 3.77 Bn in 2026 and is expected to reach USD 5.23 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.8% from 2026 to 2033. The latest report by Coherent Market Insights indicates strong growth potential for the Fish Oil Market from 2026 to 2033, supported by rising industry demand, expanding applications, and ongoing technological advancements. The
Art Materials Market See Incredible Growth 2026-2033 | Faber-Castell AG, Winsor & Newton, Chartpak, Inc.
Art Materials Market See Incredible Growth 2026-2033 | Faber-Castell AG, Winsor …
The global art materials market is estimated to be valued at USD 27.67 Bn in 2026 and is expected to reach USD 43.57 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033. The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Art Materials Market. From 2026 to

All 5 Releases


More Releases for Pharma

Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring